People with acne can join an acne patient study
Part of Skin clinical trials.
This study creates a group (cohort) of patients treated for acne at a hospital to better understand acne care in real life. It may help improve future care by sharing what treatments people receive and how they do over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have acne
- You (or your parent/guardian if you’re a minor) are willing to join
- You have the kind of health insurance the study requires
- Your facial skin condition is acne (not another face skin disease)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new acne treatment in adults. It aims to see if the treatment works well and is safe for people with acne.
This study is for people aged 18 to 25 with mild, moderate, or severe facial acne, and also for healthy volunteers without acne. Researchers want to learn more about acne by taking skin samples and blood samples, and no experimental treatments are given.
This study tests a cosmetic product alongside a standard prescription acne treatment for 12 weeks, then a maintenance phase to see if the product helps improve acne and skin appearance.
This trial tests whether a supplement containing a healthy gut bacteria called Akkermansia muciniphila can help treat moderate to severe acne. It aims to see if improving gut health can reduce acne breakouts.
This trial tests whether a cream called Social Renew can improve acne symptoms and help skin heal in healthy adults. If you have visible facial acne and are between 18 and 65, you may qualify.
This trial tests an mRNA vaccine designed to target the bacteria that cause acne. It is for teenagers aged 12 to 17 with moderate to severe facial acne. The goal is to see if the vaccine is safe and may help reduce acne.
Hear when a new Acne trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.